| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 非临床CRO(元) | 450,375,224.88 | 780,867,854.83 | 361,375,678.64 | 1,089,395,105.58 |
| 临床CRO(元) | 13,368,486.10 | 27,692,820.31 | 12,851,737.50 | 46,938,455.28 |
| 其他(元) | 1,242,156.82 | 2,764,553.23 | 1,001,150.02 | 5,335,841.43 |
| 营业成本(元) | ||||
| 非临床CRO(元) | 309,358,797.54 | 579,047,760.92 | 261,454,495.92 | 728,136,808.51 |
| 临床CRO(元) | 7,700,972.83 | 20,030,331.66 | 8,085,574.29 | 28,008,702.06 |
| 其他(元) | 1,137,187.57 | 1,656,167.79 | 540,167.14 | 1,733,785.75 |
| 毛利(元) | ||||
| 非临床CRO(元) | 141,016,427.34 | 201,820,093.91 | 99,921,182.72 | 361,258,297.07 |
| 临床CRO(元) | 5,667,513.27 | 7,662,488.65 | 4,766,163.21 | 18,929,753.22 |
| 其他(元) | 104,969.25 | 1,108,385.44 | 460,982.88 | 3,602,055.68 |
| 毛利率(%) | ||||
| 非临床CRO(%) | 31.31 | 25.85 | 27.65 | 33.16 |
| 临床CRO(%) | 42.39 | 27.67 | 37.09 | 40.33 |
| 其他(%) | 8.45 | 40.09 | 46.05 | 67.51 |
| 收入构成(%) | ||||
| 非临床CRO(%) | 96.86 | 96.25 | 96.31 | 95.42 |
| 临床CRO(%) | 2.88 | 3.41 | 3.43 | 4.11 |
| 其他(%) | 0.27 | 0.34 | 0.27 | 0.47 |
| 毛利构成(%) | ||||
| 非临床CRO(%) | 96.07 | 95.84 | 95.03 | 94.13 |
| 临床CRO(%) | 3.86 | 3.64 | 4.53 | 4.93 |
| 其他(%) | 0.07 | 0.53 | 0.44 | 0.94 |